CLL

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

CLL
Jun 17, 2025, 09:52 | Insight
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Toby Eyre, CLL specialist at the Oxford University Hospitals, shared a post on X: "Big…
May 27, 2025, 08:45 | Insight
Vincent Rajkumar: Incredible Story of How Ibrutinib Came About in CLL by Jeff Sharman
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…
Apr 23, 2025, 17:13 | Science
Joshua Brody Highlights Consensus Statement on Richter Syndrome in Blood Journal
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared an…
Apr 20, 2025, 09:19 | Science
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an…
Apr 18, 2025, 17:19 | Insight
MD Anderson Research Highlights
Insights into AML, overcoming radiotherapy resistance, and new treatment strategies for patients with blood cancers…
Apr 15, 2025, 15:26 | Science
Miguel Bronchud: How to Sequence Therapies in a Patient With Relapsed CLL
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared an article by Neil E Kay, et…
Apr 1, 2025, 12:16 | Blog
Maryam S. Yazdy: From FDA to BeiGene - Embracing a New Chapter
Maryam S. Yazdy, Senior Physician on the Lymphoma team in the Division of Hematologic Malignancies…
Apr 1, 2025, 02:06 | Blog
Vraj Rangrej: Revolutionising Approaches to Lymphoma and CLL Therapies
Vraj Rangrej, Visiting medical student at NewYork-Presbyterian Hospital, shared a post on LinkedIn: "Revolutionising Approaches…
Mar 6, 2025, 09:39 | Blog
Research funding available for early-career oncologists - Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation shared a post on X: "Attention early-career oncologists! Apply for…
Feb 1, 2025, 13:44 | Science
CLL12 study supports using the watch-and-wait approach for early-stage CLL
Jonathan Friedberg, Director of Wilmot Cancer Institute, shared a recent article by Petra Langerbeins, et…
Jan 29, 2025, 15:40 | Oncologist Near Me
Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment
Welcome to OncoDaily's special section “Oncologist Near Me” where we introduce prominent oncologists from around the world.…
Jan 21, 2025, 06:46 | Blog
Rahul Banerjee: Updates in chronic lymphocytic leukemia at BTFHem25
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X: “Good…
Jan 15, 2025, 16:13 | Insight
Nihar Desai: A case of elevated white cell count in a 60-year-old male
Nihar Desai, Bone Marrow Transplant Physician at Princess Margaret Cancer Center, shared a post on…
Dec 27, 2024, 17:35 | Blog
Rahul Gosain: CLL Highlights with John Allan
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Dec 25, 2024, 03:00 | Insight
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared on X…
Dec 22, 2024, 04:58 | Blog
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 13, 2024, 05:30 | Blog
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
New insights show Black, Hispanic, and Asian patients have more negative emotional experiences and outlooks…
Dec 11, 2024, 10:44 | Blog
Exploring New Frontiers in Chronic Lymphocytic Leukemia Treatment - City of Hope
City of Hope shared a post on LinkedIn: "City of Hope physicians and scientists are…
Dec 6, 2024, 10:38 | Blog
Nitin Jain: Unraveling Variability in TP53 Aberrant CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 5, 2024, 16:26 | Insight
Nitin Jain: Update on Pirto Ven and Obin triplet in firstline CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 3, 2024, 09:45 | Blog
Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL
National Comprehensive Cancer Network shared a post on LinkedIn: "Join us for live symposia this…
Dec 2, 2024, 19:24 | Insight
Naveen Pemmaraju: PVO combination program for frontline CLL treatment
Naveen Pemmaraju shared a post on X: '' ASH Kudos to Dr. Nitin Jain for an…
Nov 14, 2024, 16:13 | Insight
Aaron Goodman: Hematology Fellow Board Review
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared…
Oct 18, 2024, 16:33 | Blog
Jonathan Friedberg: End Point Surrogacy in First-Line CLL
Jonathan Friedberg, Director of Wilmot Cancer Institute, posted the following on X: “End Point Surrogacy in…
Sep 7, 2024, 10:15 | Insight
Leo Meriranta: KLHL6 targeting the B-cell receptor and lymphoma mutations
Leo Meriranta shared on X: “Friends! I am super-excited to share our story on KLHL6…
Sep 4, 2024, 16:08 | Blog
National Cancer Institute of Kenya commemorates World CLL Day 2024
National Cancer Institute of Kenya shared a post on X: ''Today, we commemorate World CLL…
Sep 2, 2024, 09:00 | Blog
The Max Foundation's CEO shares a powerful message of commitment honoring those living with CLL
The Max Foundation shared a post on LinkedIn: "Today, our CEO Pat Garcia-Gonzalez shares a…
Sep 2, 2024, 03:14 | Insight
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials
Othman Al-Sawaf, Haematologist and Medical Oncologist at the University Hospital Cologne, Cologne, Germany, shared a…
Aug 28, 2024, 11:11 | Blog
MD Anderson Research Highlights
Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a…
Aug 24, 2024, 10:51 | Insight
Shahrin Ahmed: High health care utilization and poor survival rate in older adults with AML
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Older…
Aug 7, 2024, 12:11 | Insight
Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation
Chronic lymphocytic leukemia (CLL) is a mature B cell disease identified by the aberrant expression…
Aug 6, 2024, 20:54 | Blog
The Max Foundation and BeiGene partner for CLL treatment in LMICs
The Max Foundation shared a post by BeiGene on LinkedIn: "We're grateful for the opportunity…
Jul 8, 2024, 10:45 | Blog
Treatment of Chronic Lymphocytic Leukemia and Richter's transformation - VJHemOnc
VJHemOnc shared a post on X: “Do not miss out on our recent session from…
Jul 2, 2024, 04:51 | Insight
Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH
ASH shared a post on X: "A new study in Blood Advances find that patients…
Jul 1, 2024, 19:24 | Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jun 24, 2024, 02:19 | Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X:                   . "Delighted…
Jun 12, 2024, 14:46 | Insight
Elisa ten Hacken: Finally, the seminars in the Hematology Review Series on CLL have been published
Elisa ten Hacken, Assistant Professor at Weill Cornell Medicine, shared a post on X: "Excited…
Jun 11, 2024, 14:59 | Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
Jun 10, 2024, 16:08 | Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
May 22, 2024, 01:53 | Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
May 10, 2024, 11:47 | Blog
Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…
May 2, 2024, 09:25 | Blog
Rahul Gosain: HemeSeries with Nitin Jain
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "HemeSeries:…
Apr 29, 2024, 00:16 | Insight
Kate Cwynarski: Wonderful talk by Philippe Gaulard
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared on X/Twitter:…
Mar 19, 2024, 03:44 | Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Dec 5, 2023, 12:57 | Drugs
Toby Eyre: Big news in CLL
Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter: "Big news in CLL.…
Oct 15, 2023, 15:13 | Blog
John Byrd: So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL.
John Byrd, Chair at the Department of Internal Medicine, University of Cincinnati College of Medicine, shared on…
Aug 31, 2023, 18:42 | Blog
Piers Blombery: Well done to Martin Vu for publishing this important health economic analysis on the cost-effectiveness of TP53/IGHV molecular testing in chronic lymphocytic leukemia in Australia.
All: 47 Posts: 1 - 100
Special Coverage